Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

BONANNI, Laura;
2016-01-01

Abstract

Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers.
File in questo prodotto:
File Dimensione Formato  
van Steenoven (2016) Cerebrospinal Fluid Alzheimers Disease Biomarkers Across the Spectrum of Lewy Body Diseases Results from a Large Multicenter Cohort.pdf

Solo gestori archivio

Descrizione: Articolo Principale
Tipologia: Documento in Post-print
Dimensione 205.83 kB
Formato Adobe PDF
205.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/655767
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 74
  • ???jsp.display-item.citation.isi??? 69
social impact